The neuropeptide alpha-melanocyte-stimulating hormone: a key component of neuroimmunomodulation. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The neuropeptide alpha-melanocyte-stimulating hormone: a key component of neuroimmunomodulation.

Neuroimmunomodulation. 1994 Mar-Apr;1(2):93-9. Unique Identifier : AIDSLINE MED/96053018
Catania A; Lipton JM; First Medical Clinic, University of Milan, Italy.


Abstract: Recent research indicates that the proopiomelanocortin derivative alpha-melanocyte stimulating hormone (alpha-MSH) is a significant modulator of host reactions including fever and inflammation. Although the precise mechanism of action is still unknown, cytokine antagonism is believed to be responsible for at least a part of its anti-inflammatory/antipyretic influence: alpha-MSH antagonizes pyrogenic and proinflammatory effects of cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor (TNF), and interferon gamma (IFN gamma). Although it is clear that the peptide can act within the brain to inhibit fever and peripheral inflammation, an anti-inflammatory effect on a peripheral target was evidenced in animals with transection of the spinal cord. Recent data show that alpha-MSH is significant also in human disorders such as AIDS, rheumatoid arthritis, and myocardial infarction. This molecule is believed to be a key factor in neuroimmunomodulation and it may be useful as a therapeutic agent in control of inflammatory reactions.
Keywords: alpha-MSH/*PHYSIOLOGY/THERAPEUTIC USE Acquired Immunodeficiency Syndrome/BLOOD/PHYSIOPATHOLOGY Amino Acid Sequence Animal Anti-Inflammatory Agents, Non-Steroidal/THERAPEUTIC USE Arthritis/BLOOD/DRUG THERAPY/PHYSIOPATHOLOGY Female Fever/DRUG THERAPY/PHYSIOPATHOLOGY Human Inflammation/DRUG THERAPY/*PHYSIOPATHOLOGY Mice Mice, Inbred BALB C Molecular Sequence Data Myocardial Infarction/BLOOD/PHYSIOPATHOLOGY Neuroimmunomodulation/*PHYSIOLOGY Pulmonary Edema/DRUG THERAPY/PHYSIOPATHOLOGY Rabbits Rats Shock, Septic/BLOOD/DRUG THERAPY/PHYSIOPATHOLOGY Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE REVIEW REVIEW, TUTORIALKWDalpha-msh/
960330
M9630741

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .